TYSABRI® (natalizumab) is a prescription infusion medication used to treat adults with multiple sclerosis or moderate to severe Crohn’s disease when other forms of treatment have failed to provide relief. It has proven effective in decreasing symptoms and preventing flare-ups. It is unknown whether the medication is effective in children under 18 years of age.
Please refer to the full prescribing information.
Note: Please speak with your healthcare provider for more information if you think this therapy might be right for you.
How do I make a referral or transition my treatment to Infusion Associates?
3. One of our intake specialists will contact your healthcare provider to confirm receipt of your referral.
4. We will then verify benefits, obtain any required prior authorizations, and contact you to schedule an appointment.